Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0027819 (
neuroblastoma
)
27,800
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
1. Activities of
acetylcholinesterase
(
AChE
), neuropathy target esterase (NTE), and carboxylesterase (CbxE) were compared in
neuroblastoma
cells of human origin (SH-SY5Y) and murine origin (NB41A3). 2. Mouse
neuroblastoma
cells had lower specific activities of NTE and CbxE than did human
neuroblastoma
cells; specific activities in the murine cells correlated with specific activities in mouse brain. 3.
AChE
activities in mouse and human
neuroblastoma
cells were considerably lower than
AChE
activities in mouse or hen brain. 4. Inhibition of esterases did not demonstrate interspecies differences for 12 of the 17 anti-esterase compounds tested with human and mouse
neuroblastoma
cells.
...
PMID:Esterase comparison in neuroblastoma cells of human and rodent origin. 755 40
Although the neurotoxicity of organophosphorus compounds is generally attributed to inhibition of
acetylcholinesterase
, recent reports have indicated that direct interactions with muscarinic receptors and signal transduction may be an additional mechanism of neurotoxicity. We have previously shown that the organophosphorus insecticide O,O-diethyl O-3,5,6-trichloro-2-pyridinyl phosphorothioate (chlorpyrifos) binds directly to muscarinic receptors and inhibits adenylate cyclase of rat striatum. We have further pursued those results in this study by investigating the effect of chlorpyrifos oxon in NG108-15
neuroblastoma
-glioma cells and Chinese hamster ovary cells transfected with cDNA for human m2 or m4 muscarinic receptor subtypes. At millimolar concentrations, chlorpyrifos oxon inhibited [3H]QNB binding in all cell lines. Likewise, [3H]CD binding was inhibited in NG108-15 and CHO-Hm2 cells. When the effect of chlorpyrifos oxon on adenylate cyclase was examined, the oxon was found to inhibit adenylate cyclase at millimolar concentrations. Though this effect on cyclase required greater concentrations of oxon than the comparable effect in striatal cells, it displayed the common characteristic of being atropine-insensitive, suggesting that the effect on cyclase was not muscarinic receptor dependent. The inhibition of adenylate cyclase produced by chlorpyrifos oxon was not eliminated in pertussis toxin treated cells, lending further support to the idea that it is not a receptor-mediated event, and suggesting a potential direct interaction of chlorpyrifos oxon with the adenylate cyclase molecule.
...
PMID:In vitro effect of chlorpyrifos oxon on muscarinic receptors and adenylate cyclase. 756 87
All-trans-retinoic acid (ATRA) has been shown to be one of the most potent chemical inducers of human
neuroblastoma
differentiation. The recent discovery that the stereoisomer of ATRA, 9-cis-retinoic acid (9-cis-RA), binds to both the retinoic acid and retinoid X series of receptors prompted us to evaluate the ability of this compound to promote differentiation of this cell type. Using the LA-N-5 cell line, we have now determined that 9-cis-RA can induce the differentiation of human
neuroblastoma
cells as evidenced by dose-dependent inhibition of cell proliferation, neurite outgrowth, increased
acetylcholinesterase
activity, and reduction of N-myc mRNA expression. In comparing the effects of 9-cis-RA to ATRA, we found that while both compounds induced qualitatively similar cholinergic (versus adrenergic) features in LA-N-5 cells, 9-cis-RA was 5-to-10-fold more potent than ATRA in its antiproliferative and differentiation activity. These results were supported by transient transfection experiments utilizing chloramphenicol acetyltransferase (CAT) plasmid constructs containing a retinoic acid responsive regulatory element which showed a 2-to-3-fold increase in reporter gene activity induced with 9-cis-RA over that seen with ATRA at pharmacologically relevant retinoid concentrations (> 10(-8) M). Furthermore, we have determined that 9-cis-RA can significantly enhance mRNA levels of the nuclear retinoic acid receptors alpha and beta in LA-N-5 cells. Taken together, these findings have established the ability of 9-cis-RA to induce
neuroblastoma
differentiation and suggest that this retinoic acid isomer may have better therapeutic characteristics than ATRA.
...
PMID:Enhanced potency of 9-cis versus all-trans-retinoic acid to induce the differentiation of human neuroblastoma cells. 758 96
We investigated the effect on differentiation of genistein, an inhibitor of tyrosine protein kinase, and 1-(-5 isoquinolinylsulfonyl)-2-methylpiperazine (H7), an inhibitor of protein kinase C, in
neuroblastoma
cell lines. Growth inhibition and expression of morphological and biochemical properties were examined in the human
neuroblastoma
cell lines TS12 and SJNKP. Genistein and H7 induced neurite outgrowth, increased
acetylcholinesterase
activity and cell growth inhibition in both cell lines. These results underline that tyrosine protein kinase and protein kinase C may play a key role in the control of differentiation and proliferation of neural cells.
...
PMID:Inhibitors of protein kinases induce differentiation in human neuroblastoma cell lines. 765 25
1. Organophosphates can cause acute toxicity, which follows inhibition of
acetylcholinesterase
(
AChE
), or delayed neuropathy, which follows inhibition of neuropathy target esterase (NTE). 2. Human
neuroblastoma
SH-SY5Y cells contain
AChE
and NTE. 3. Organophosphates actively able to inhibit
AChE
in animal models inhibited
AChE
in
neuroblastoma
cells. 4. Inhibition of NTE in
neuroblastoma
cells could identify active organophosphates capable of causing delayed neuropathy in animal models and distinguish these organophosphates from those that do not cause delayed neuropathy in animal models.
...
PMID:Using neuroblastoma cell lines to address differential specificity to organophosphates. 767 43
Our intent was to evaluate the C1300
neuroblastoma
cell as an in vitro system for studying the mode of action and efficacy of drugs used to treat or prevent organophosphate intoxication. The anticholinergic drugs hexamethonium, trimethaphan, and hemocholinium and the triethylcholine and
cholinesterase
/reactivator 2-pyridine aldoxime methochloride (2-PAM) have been shown to be effective in preventing intoxication by diisopropyl phosphorofluoridate (also known as diisopropyl fluorophosphate, DFP) in vivo. We determined their efficacy in preventing cell death (as measured by trypan blue exclusion) of
neuroblastoma
cells alone or in combination. We also determined their efficacy in reversing the cytotoxic effects of DFP on cell DNA synthesis (as measured by [3H]-thymidine incorporation), cell RNA synthesis (as measured by [3H]uridine incorporation), and on cell protein synthesis (as measured by [3H]leucine incorporation). The maximal nontoxic doses of the drugs in vitro were determined. All anticholinergic agents studied reduced the cytotoxicity of DFP using one or more parameters. 2-PAM, the
cholinesterase
reactivator, enhanced the cytotoxicity of DFP on cultured cells at a high concentration (1 mg/mL) and reduced it at a lower concentration (0.3 mg/mL). All four anticholinergic agents were capable of enhancing the uptake of [3H]thymidine. Only hexamethonium and hemicholinium reversed DFP inhibition of DNA synthesis. RNA synthesis was not affected by any anticholinergic agent and no agent reversed DFP inhibition of RNA synthesis. Protein synthesis was enhanced by every anticholinergic agent except hemicholinium; the inhibition of protein synthesis by DFP was reversed by trimethaphan and triethylcholine.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:Use of C1300 neuroblastoma cells to evaluate the protective value of hexamethonium, trimethaphan, hemicholinium, and triethylcholine against diisopropyl phosphorofluoridate toxicity. 771 47
The present paper reports how aluminium [Al(III)] at a concentration of 3.7 microM can activate the bovine erythrocytic enzyme
acetylcholinesterase
(
AChE
) by about 38% in vitro. This same activating effect was observed on
AChE
form human as well as from rat erythrocyte ghosts and murine
neuroblastoma
cells. The interaction between Al3+ and gamma-peripheral sites of the enzyme produces
AChE
structural modifications as evidenced by circular dichroism measurements. This may provide a molecular explanation of the raised enzymatic activity.
...
PMID:Activation of acetylcholinesterase by aluminium(III): the relevance of the metal species. 782 30
Phenylacetate, a natural metabolite of phenylalanine which was originally described as a plant growth hormone, has recently gained attention as a possible differentiation inducer for a variety of human tumor cell types. This interest prompted us to assess the ability of sodium phenylacetate (NaPA) to promote the differentiation of human
neuroblastoma
cells, both alone and in combination with retinoic acid (RA), a known inducer of
neuroblastoma
differentiation and maturation. Using the LA-N-5 cell line, we have determined that NaPA can stimulate the differentiation of
neuroblastoma
cells, as evidenced by dose-dependent inhibition of cell proliferation, neurite outgrowth, increased
acetylcholinesterase
activity and reduction of N-myc expression. Furthermore, NaPA and RA synergized in inducing differentiation, in that combination treatment resulted in cessation of cell growth along with morphologic and biochemical changes indicative of the loss of malignant properties. We have determined that NaPA can markedly enhance mRNA levels of the nuclear RA receptor-beta (RAR beta) in LA-N-5 cells prior to morphologic or other phenotypic changes induced by this compound. This effect appeared to be distinct from the ability of NaPA to alter tumor cell lipid metabolism via inhibition of protein isoprenylation. Thus among its varied effects on LA-N-5 cells, NaPA appears to interact with the RA pathway at the nuclear level by up-regulating RAR beta expression.
...
PMID:Phenylacetate synergizes with retinoic acid in inducing the differentiation of human neuroblastoma cells. 782 65
In the human
neuroblastoma
cell line LA-N-2, recombinant rat ciliary neurotrophic factor (CNTF) induced neurite growth and cholinergic differentiation that were both half-maximally saturated at < 100 pM of the neurokine, but was not required for cell survival in serum-free conditions over a 13-day period. CNTF markedly stimulated choline acetyltransferase activity and acetylcholine synthesis, whereas high-affinity choline transport was only slightly enhanced and
acetylcholinesterase
activity was unchanged. Leukemia inhibitory factor had effects identical to CNTF on neurite growth and choline acetyltransferase activity, but interleukin 6 had no effect. Radioiodinated CNTF binding and affinity cross-linking studies were consistent with tripartite receptor activation as a mediator of the observed biological effects.
...
PMID:Differentiation effects of ciliary neurotrophic factor on human neuroblastoma cells. 789 Oct 74
We have observed that cultured neurons from chick spinal cord and the
neuroblastoma
hybrid line 108CC15 released lower amounts of
acetylcholinesterase
(
AChE
) when compared with the parental line, N18TG2.
AChE
activity extracted by hypotonic buffer, which can be regarded as the source of the released enzyme, was considerably higher in the parental than in the hybrid 108CC15 (respectively, approximately 80% and approximately 40% of cellular activity). On the other hand, evaluation of ectocellular, with respect to total,
AChE
activity showed that in N18TG2 cells only 7% of
AChE
was localized on the plasmalemma, whereas in the hybrid line the percentage of ectocellular activity was 3.7 times higher than in the parental line. We have also examined the effect of cytochalasin B and nocodazole. In the N18TG2 line, the former did not affect
AChE
release, which was significantly reduced by the latter. High K+ level in the culture medium, of both N18TG2 and hybrid 108CC15 cultures, induced an increase in
AChE
secretion; Ca2+ presence was required for high K(+)-induced release. Muscle extracts increased
AChE
secretion in both the hybrid 108CC15 and the spinal cord neurons. The present data suggest that
AChE
secretion during neuronal development is modulated by depolarizing stimuli and by soluble factors produced by target cells and may be involved in the control of neuronal differentiation.
...
PMID:Characterization of acetylcholinesterase secretion in neuronal cultures and regulation by high K+ and soluble factors from target cells. 789 Oct 79
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>